YKL-40 as a new promising prognostic marker of severity in COVID infection.

Schoneveld, Lauranne; Ladang, Aurélie; Henket, Monique; Frix, Anne-Noëlle; Cavalier, Etienne; Guiot, Julien

Schoneveld, Lauranne; Ladang, Aurélie; Henket, Monique; Frix, Anne-Noëlle; Cavalier, Etienne; Guiot, Julien.

Schoneveld L; Department of Clinical Chemistry, University of Liege, CHU de Liège, Domaine Universitaire du Sart-Tilman, B35, 4000, Liège, Belgium.
Ladang A; Department of Clinical Chemistry, University of Liege, CHU de Liège, Domaine Universitaire du Sart-Tilman, B35, 4000, Liège, Belgium.
Henket M; Department of Pneumology, CHU de Liège, Liège, Belgium.
Frix AN; Department of Pneumology, CHU de Liège, Liège, Belgium.
Cavalier E; Department of Clinical Chemistry, University of Liege, CHU de Liège, Domaine Universitaire du Sart-Tilman, B35, 4000, Liège, Belgium. etienne.cavalier@chuliege.be.
Guiot J; Department of Pneumology, CHU de Liège, Liège, Belgium.

Crit Care ; 25(1): 66, 2021 02 16.

Article in English | MEDLINE | ID: covidwho-1088609

Subject(s)

COVID-19/blood; COVID-19/therapy; Chitinase-3-Like Protein 1/blood; Severity of Illness Index; Aged; Aged, 80 and over; Biomarkers/blood; Female; Humans; Intensive Care Units/statistics & numerical data; Male; Middle Aged; Patient Admission/statistics & numerical data; Prognosis; Retrospective Studies

Keywords

COVID-19; Chitinase 3-like 1; Interstitial lung disease; SARS-CoV-2; YKL-40

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severity of Illness Index / Chitinase-3-Like Protein 1 / COVID-19 Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Crit Care Year: 2021 Document Type: Article Affiliation country: S13054-020-03383-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google